Echo Street Capital Management’s Royalty Pharma RPRX Stock Holding History

Echo Street Capital Management’s Portfolio RPRX Stock Details RPRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-42,317	Closed	-$1.15M	–	349
2023 Q3	$1.15M	Buy	42,317 +20,628	+95%	+$613K	0.01%	131
2023 Q2	$667K	Buy	21,689 +9,179	+73%	+$311K	0.01%	202
2023 Q1	$451K	Sell	12,510 -13,373	-52%	-$496K	﹤0.01%	280
2022 Q4	$1.02M	Buy	25,883 +13,965	+117%	+$583K	0.01%	150
2022 Q3	$479K	Buy	+11,918	New	+$509K	﹤0.01%	281
2022 Q2	–	Sell	-27,142	Closed	-$1.06M	–	689
2022 Q1	$1.06M	Buy	+27,142	New	+$1.07M	0.01%	214

Other funds holding RPRX

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Echo Street Capital Management's RPRX Position: Q4 2023 in Review

Echo Street Capital Management sold out of Royalty Pharma (RPRX) in Q4 2023, closing a stake of 42,317 shares — an estimated $1.15M sold.

Echo Street Capital Management first reported a position in RPRX in Q1 2022 and held it in 6 quarters. The position peaked at $1.15M in Q3 2023. 363 funds tracked by Wall St. Rank hold RPRX as of Q4 2023.

Echo Street Capital Management reported no remaining Royalty Pharma position as of Q4 2023 after selling out during the quarter.
Echo Street Capital Management sold 42,317 Royalty Pharma shares in Q4 2023, an estimated $1.15M.
Echo Street Capital Management first reported a position in Royalty Pharma in Q1 2022 and held it in 6 quarters.
Echo Street Capital Management's Royalty Pharma position peaked at $1.15M in Q3 2023.
363 funds tracked by Wall St. Rank held Royalty Pharma as of Q4 2023.

Based on Echo Street Capital Management's 13F filing for Q4 2023, filed 8 Feb 2024.